Brief: Shield Therapeutics Expects to Deliver Operating Profit In 2026
21/01/2026 07:46
Jan 21 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS - Q4 2025 TRADING UPDATE SHIELD THERAPEUTICS PLC - EXPECTS OPERATING PROFIT IN 2026 Source text: ID:nRSU6821Pa Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update